Ichor Medical Systems, based in San Diego, CA, is a leading company dedicated to the clinical application and commercialization of their TriGrid electroporation technology. Their technologically superior and clinically tested TriGrid Delivery System enables enhanced, tolerable, and reproducible administration of nucleic acid-based biologics, supporting the development and commercialization of drug products. With strong IP protection and established manufacturing capabilities, Ichor seeks strategic partnerships to expand the product pipeline in nucleic acid-based biologics.
Driven by a mission to deliver on the promise of nucleic acid-based medicines, Ichor focuses on treating a wide range of disease indications, including cancer, chronic viral infections, HIV, and multiple biodefense agents. Their TriGrid technology has been licensed by renowned companies like Pfizer and Janssen for the delivery of their proprietary DNA vaccines, while also receiving funding from the US government for DNA-based antibody delivery. Ichor Medical Systems continues to be at the forefront of innovation in the field, offering a reliable and automated solution for nucleic acid administration.
Generated from the website